Todos Medical, Ltd. TOMDF
We have been tracking TOMDF since Tuesday morning in the premarket, when we included it in our extended watchlist. At the time, it was trading for as little as .0413 per share, and while it had a solid session that day, the gains hadn’t quite yet cracked the double-bag threshold.
Yesterday, after another really good performance, that mark was attained and then some. TOMDF has gone on to hit a new high of .17 for us, which works out to a big gain of 312%
The company’s rapid (2-10min) COVID-19 point-of-care test has been the primary reason for the stock’s huge moves. We will stay updated on the progress of the company getting the tests put into action, and will be interested to see if more upswings are on the horizon as a result.
We signaled a range of options in the GILD chain in yesterday morning’s report. with the GILD Weekly $79-81 Calls. Thanks to a pretty good day for the markets, all things considered, we witnessed some very nice moves out of those targets.
Weekly $79-81 Calls
$79: 3.44-8.00 (+133%)
$80: 2.68-7.42 (+177%)
$81: 2.49-6.05 (+143%)
CRWD Weekly $47.50-50 Calls & 03/27 $52-53.50 Calls
TNXP, NBP, WTRH, BLPH, AMTX, PIXY, CEMI
Todos Medical, Ltd. TOMDF
The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.
In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of 0413, and reached a high of .08, which works out to an intraday upswing of 94%
While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.
While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:
CPB, APRN, CLX, GIS, PG
MATN, ZOOM, DECN, PCTL, NBDR, IPIX, GNPX, GNBT
Target Corp. TGT
Just as we mentioned yesterday morning to start off the week, it was on Thursday morning that we signaled our interest in tracking some TGT Puts. They hadn’t quite heated up yet by the end of last week, but we urged readers yesterday to pay close attention, as the gains seemed imminent.
We were correct in that assumption, as the markets once again set a new record for worst daily losses in history. That helped propel the massive range of contracts we signaled, the TGT 04/03 $98-90 Puts, to double-bag gain status and beyond, exactly as we predicted.
Here are the trading ranges on those contracts since we’ve had them on our radar:
TGT 04/03 $98-90 Puts
$98: 3.37-6.92 (+105%)
$97: 2.90-6.60 (+128%)
$96: 2.73-6.00 (+120%)
$95: 2.21-5.95 (+169%)
$94: 2.54-5.50 (+117%)
$93: 1.99-5.05 (+154%)
$92: 2.44-4.50 (+84%)
$91: 2.00-4.25 (+113%)
$90: 1.47-3.80 (+156%)
Transdigm Group, Inc TDG
We would like to put together a set of call contracts to watch in the TDG chain. It’s no surprise that the stock is at a bottom at present, but what is remarkable is the amount of insider buying that has taken place in the last week, to the tune of roughly $180M.
That typically signals an insider’s confidence that the stock will not fall much further. We are going to put the TDG 05/15 $350-370 Calls on watch to track in the weeks ahead.
CODX, AYTU, IBIO, MBRX, APT, SPCE, TOMDF